
The median survival time of adults with supratentorial malignant glioma treated in clinical studies with surgery, 6 weeks of external-beam radiotherapy, and carmustine (BiCNU) is approximately 1 year. This poor survival time

Your AI-Trained Oncology Knowledge Connection!


Published: March 1st 1995 | Updated: